ArticleTherapeutic advances in neurological disorders2026
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.
Andrea Surcinelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.